What question did this study set out to answer?

This research aims to assess the cost-effectiveness of guided statin treatment for individuals with borderline cardiovascular risk and high LDL cholesterol levels.

August 28, 2019JAMA CardiologyOpen Access

Cost-effectiveness of Low-density Lipoprotein Cholesterol Level–Guided Statin Treatment in Patients With Borderline Cardiovascular Risk

View Full Paper

Ask AI

Bookmark

Authors

CKCiaran Kohli‐LynchGeneral / Preventive / Lipids BBBrandon K. BellowsTwitter (United States)GTGeorge ThanassoulisPreventive Cardiology

Discussion

Member takes

Implication

Randomized trial estimates cost-effectiveness of statin strategies in borderline ASCVD patients, suggesting broader treatment eligibility may be beneficial.

Key Points

This research aims to assess the cost-effectiveness of guided statin treatment for individuals with borderline cardiovascular risk and high LDL cholesterol levels.
Evaluated 100 simulated cohorts of 1 million healthy adults using probabilistic sampling from national health surveys.
Applied the CVD Policy Model microsimulation to project lifetime health outcomes and costs.
Compared four statin treatment strategies across various demographic and health risk strata.
Treating individuals with borderline AR10 and LDL-C levels of 160 to 189 mg/dL was cost-saving.
Further treatment for LDL-C levels of 130 to 159 mg/dL was also cost-saving.
Overall treatment for all patients with AR10 of at least 5.0% yielded a cost-effectiveness of $33,558 per QALY.

Cite This Study

Kohli‐Lynch et al. (2019) studied this question.

synapsesocial.com/papers/6a63dec3de6e3d49e3f2ddf6 https://doi.org/10.1001/jamacardio.2019.2851

View Full Paper

Ask AI

Bookmark

Implication

Randomized trial estimates cost-effectiveness of statin strategies in borderline ASCVD patients, suggesting broader treatment eligibility may be beneficial.

Cost-effectiveness of Low-density Lipoprotein Cholesterol Level–Guided Statin Treatment in Patients With Borderline Cardiovascular Risk

Discussion

Member takes

Implication

Key Points

Cite This Study

Cost-effectiveness of Low-density Lipoprotein Cholesterol Level–Guided Statin Treatment in Patients With Borderline Cardiovascular Risk

Discussion

Member takes

Implication

Key Points

Cite This Study

Also Consider

Also Consider